Dermatology company Galderma’s main focus is to ensure that customer’s needs are met using high service standards for existing, as well as new dermatological products. A constant priority is strict compliance with worldwide standards in quality, safety and environment, and we take pride in the fact that these are an integral part of our company's everyday work. The Manufacturing & Technical Operations teams manage all the supply activities, including purchasing and plant and contractor supply chain leadership. We strive to maintain optimal performance, while encouraging employees to be innovative in every area.

To deliver dermatology solutions and products offering the best quality, cost and service benefits the company’s manufacturing capacity is spread across the following sites. In 2014, the six sites produced 200 million units.


Alby-sur-Chéran, France

Laboratoires Galderma SAS
Zone Industrielle - Touvière
74540 Alby sur Chéran - France
Phone: +33 (0)1 58 86 45 45 - Fax: +33 (0)4 50 68 31 33

With a workforce of 330, the dermatology company’s French site has an annual production capacity of more than 45 million units. It manufactures the liquid and semi-liquid forms of products on 7 platforms and 11 production lines and supplies over 70 countries in Europe, the Middle East, Africa, Australia, Asia and South America. The site has received ISO 14001 and OHSAS 18001 certifications and has been certified by several Health Agencies. 

Galderma’s sixty-strong Industrial Development team is also based at the Alby-sur-Chéran site in the French Alps. The unit develops and improves manufacturing processes for new dermatology solutions and products, acquisitions and transfers, and supplies reference raw materials. It also produces clinical batches for trials worldwide. Industrial Development is tasked with leveraging dermatology company Galderma’s technical process.


Uppsala, Sweden

Galderma Uppsala, Legal entity: Q-Med AB
Seminariegatan 21
Visiting address: Fyrisvallsgatan 7
75228 Uppsala - Sweden
Phone: +46 18 474 90 00 - Fax: +46 18 474 90 01

Galderma's site in Uppsala, Sweden is the Global Aesthetic Center of Excellence with nearly 450 employees as well as world-class research and manufacturing. The site is responsible for Innovation, Development, Manufacturing and Strategic brand management for aesthetic and corrective treatments. A majority of the products in the aesthetic & corrective portfolio is based on the company’s patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid.

The manufacturing site employs 240 people and has served the market worldwide with leading brands like Restylane since 1996.


Montreal, Canada

G Production Inc.
19400 Trans-Canada Hwy
Baie d'Urfé, Québec
H9X 3S4 - Canada
Phone: +1 514 457 33 66 - Fax: +1 514 457 83 99

Employing 370 people, dermatology company, Galderma’s Canadian site, near Montreal, has eight manufacturing platforms and nine packaging lines (11 in the near future) offering a combined annual production capacity of 100 million units. Cream, lotion and ointment forms are manufactured here: pharmaceutical products for the US market and non-prescription products for all the markets worldwide. The plant is ISO 14001, OHSAS 18001 as well as CTPAT, FDA, ANVISA and Health Canada.


HortolandiaHortolândia, Brazil

Galderma Brasil Ltda.
Rodovia SP 101 - Campinas-Monte Mor, Km 9
Condominio Techtown - CEP 13186-904
Hortolândia-SP - Brazil
Phone: +55 19 3045 6900 - Fax: +55 19 3845 5261

Galderma's Brazilian site came on stream in November 2004 and today employs about 104 people. Specializing in liquid and semi-solid forms, it offers an annual production capacity of 8 million units split in pharmaceutical and consumer skin health products. The site is ISO 14001, OHSAS 18001 as well as ANVISA and INVIMA certified. Products manufactured here are shipped mainly throughout Brazil and Latin America.


Egerkingen, Switzerland

Galderma Spirig
Spirig Pharma AG
Froschackerstrasse 6
4622 Egerkingen – Switzerland
Phone: +41 (0) 62 387 87 87 - Fax: +41  (0) 62 387 87 99

The annual production of app.30 Mio units, initially for 12 markets, will supply over 48 countries in Europe, the Middle East, Africa, Australia, Asia and South America. With a workforce of 164 employees the plant produces liquid, semi-solid and solid dosage forms.

Galderma’s Self-medication business and R&D unit are also situated in Egerkingen, as is Galderma’s Swiss affiliate.


Soest, Germany

Bübchen-Werk Ewald Hermes
Pharmazeutische Fabrik GmbH 
Coesterweg 37
59494 Soest 
Phone: +49 (0) 2921/706-0 - Fax: +49 (0) 2921/706-59

Counting more than 110 employees, this baby care site in Germany has an annual production capacity of around 45 million units. With the support of the R&D facilities the site manufactures fluids such as shampoos and oils and baby creams through 4 platforms and 6 production lines. The factory’s main market is Germany, though its export products continue growing adding up to more than 20 countries in Europe, the Middle East, Australia and Asia.  
With the full commitment towards continuous excellence, the Soest Bübchen-Factory is an ISO 9001, OHSAS 18001, ISO 14001 and ISO 50001 certified site.




Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world



We are committed

See all videos